|
Medicines management supervisors (MMS)
|
SPARS –ES**
|
Supportive supervision competency score (%) median
|
Total # of SPARS visits implemented in 2012*
|
|---|
|
MMS of facilities with high SPARS-ES
|
|
MMS a (C)
|
4.0
|
56%
|
20
|
|
MMS b (P)
|
4.0
|
0%
|
6
|
|
MMS c (C)
|
3.7
|
71%
|
25
|
|
MMS d (C)
|
2.3
|
40%
|
43
|
|
MMS e (C)
|
1.6
|
77%
|
11
|
|
Median
|
3.7
|
57%
|
20
|
|
MMS of facilities with low SPARS-ES
|
|
MMS f (P)
|
1.4
|
22%
|
8
|
|
MMS g (P)
|
1.4
|
37%
|
24
|
|
MMS h (C)
|
1.1
|
22%
|
14
|
|
MMS i (P)
|
0.5
|
17%
|
19
|
|
MMS j (C)
|
0.3
|
55%
|
22
|
|
Median
|
1.1
|
24%
|
19
|
|
Median overall
|
2.0
|
38%
|
19
|
- *MMS experience defined as total number of SPARS visits implemented 2012
-
**average facility improvement in medicines management across visits by the MMS in 2012, on a scale from 0 to 25; C: clinician; P: pharmacy-trained
